These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Post-transfusion hepatitis and serum alanine aminotransferase in blood donors. N Engl J Med; 1981 Aug; 305(7):403-4. PubMed ID: 6789203 [No Abstract] [Full Text] [Related]
4. Based on your analysis of the benefits and costs of routine donor screening for ALT-GPT to reduce the incidence of post-transfusion non-A, non-B hepatitis in your blood services region, what action would you recommend on this matter? Vox Sang; 1983; 44(1):48-64. PubMed ID: 6402857 [No Abstract] [Full Text] [Related]
7. Determination of alanine aminotransferase in blood donor screening--evidence of its usefulness in the prevention of post-transfusion hepatitis. Khouri ST; Lopes EP; Perez RM; Figueiredo VM; Lanzoni VP; Silva AE; Ferraz ML Clin Lab; 2004; 50(5-6):291-4. PubMed ID: 15209437 [TBL] [Abstract][Full Text] [Related]
8. A review of donor alanine aminotransferase testing. Implications for the blood donor and practitioner. Saxena S; Korula J; Shulman IA Arch Pathol Lab Med; 1989 Jul; 113(7):767-71. PubMed ID: 2500923 [TBL] [Abstract][Full Text] [Related]
9. [Post-transfusion hepatitis]. Fiedler H Dtsch Med Wochenschr; 1989 Jul; 114(27):1090-1. PubMed ID: 2500321 [No Abstract] [Full Text] [Related]
10. Posttransfusion hepatitis. Straughn J Del Med J; 1988 Oct; 60(10):585-6. PubMed ID: 3143608 [No Abstract] [Full Text] [Related]
11. Non-B post-transfusion hepatitis associated with hepatitis B core antibodies in donor blood. Vyas GN; Perkins HA N Engl J Med; 1982 Mar; 306(12):749-50. PubMed ID: 6801510 [No Abstract] [Full Text] [Related]
12. Non-B post-transfusion hepatitis with hepatitis B core antibodies in donor blood. Katchaki JN; Siem TH; Brouwer R N Engl J Med; 1982 Sep; 307(10):628-9. PubMed ID: 6810169 [No Abstract] [Full Text] [Related]
13. Serum alanine aminotransferase of donors in relation to the risk of non-A,non-B hepatitis in recipients: the transfusion-transmitted viruses study. Aach RD; Szmuness W; Mosley JW; Hollinger FB; Kahn RA; Stevens CE; Edwards VM; Werch J N Engl J Med; 1981 Apr; 304(17):989-94. PubMed ID: 6782484 [TBL] [Abstract][Full Text] [Related]
14. [Screening of blood donors for the prevention of non-A, non-B hepatitis]. Seidl S Dtsch Med Wochenschr; 1983 Jan; 108(4):123-4. PubMed ID: 6402351 [No Abstract] [Full Text] [Related]
15. Reducing hepatitis by testing blood for alanine aminotransferase. Kahn RA N Engl J Med; 1983 Apr; 308(14):844-5. PubMed ID: 6403860 [No Abstract] [Full Text] [Related]
16. [Post-transfusional hepatitis]. de Oliveira e Silva A Arq Gastroenterol; 1985; 22(3):107-8. PubMed ID: 3939181 [No Abstract] [Full Text] [Related]
18. [Currently available means for the prevention of post-transfusion hepatitis and criteria for their application]. Bedarida G; Cambiè G; D'Agostino F; Sterza G Ric Clin Lab; 1984; 14 Suppl 1():37-60. PubMed ID: 6429830 [No Abstract] [Full Text] [Related]
19. Alanine aminotransferase and posttransfusion hepatitis. Lacher DA JAMA; 1987 Feb; 257(8):1048. PubMed ID: 3100827 [No Abstract] [Full Text] [Related]
20. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. Alter HJ; Nakatsuji Y; Melpolder J; Wages J; Wesley R; Shih JW; Kim JP N Engl J Med; 1997 Mar; 336(11):747-54. PubMed ID: 9052652 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]